Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC.
Lucibello F, Gounant V, Aldea M, Duruisseaux M, Perol M, Chouaid C, Bennouna J, Fallet V, Renault A, Guisier F, Giroux-Leprieur E, Wislez M, Toffart AC, Mazieres J, Basse C, Hegarat N, Carton M, Girard N.
Lucibello F, et al. Among authors: chouaid c.
JTO Clin Res Rep. 2024 Oct 17;6(1):100743. doi: 10.1016/j.jtocrr.2024.100743. eCollection 2025 Jan.
JTO Clin Res Rep. 2024.
PMID: 39850629
Free PMC article.